BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abusukhun M, Winkler MS, Pöhlmann S, Moerer O, Meissner K, Tampe B, Hofmann-Winkler H, Bauer M, Gräler MH, Claus RA. Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies. Front Immunol 2021;12:784989. [PMID: 34987511 DOI: 10.3389/fimmu.2021.784989] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lomova N, Dolgushina N, Tokareva A, Chagovets V, Starodubtseva N, Kulikov I, Sukhikh G, Frankevich V. Past COVID-19: The Impact on IVF Outcomes Based on Follicular Fluid Lipid Profile. Int J Mol Sci 2022;24. [PMID: 36613453 DOI: 10.3390/ijms24010010] [Reference Citation Analysis]
2 Matson J, Lange P, Honore PM, Chung KK. Adverse outcomes with extracorporeal adsorbent blood treatments in toxic systemic inflammation: a perspective on possible mechanisms. Ann Intensive Care 2022;12:105. [DOI: 10.1186/s13613-022-01078-6] [Reference Citation Analysis]
3 Péricat D, Leon-icaza SA, Sanchez Rico M, Mühle C, Zoicas I, Schumacher F, Planès R, Mazars R, Gros G, Carpinteiro A, Becker KA, Izopet J, Strub-wourgaft N, Sjö P, Neyrolles O, Kleuser B, Limosin F, Gulbins E, Kornhuber J, Meunier E, Hoertel N, Cougoule C. Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model. IJMS 2022;23:13623. [DOI: 10.3390/ijms232113623] [Reference Citation Analysis]
4 Borovcanin MM, Vesic K, Balcioglu YH, Mijailović NR. Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution. Front Psychiatry 2022;13:1052710. [DOI: 10.3389/fpsyt.2022.1052710] [Reference Citation Analysis]
5 Gouda AS, Mégarbane B. Molecular Bases of Serotonin Reuptake Inhibitor Antidepressant-Attributed Effects in COVID-19: A New Insight on the Role of Bradykinins. JPM 2022;12:1487. [DOI: 10.3390/jpm12091487] [Reference Citation Analysis]
6 Upadhyai P, Shenoy PU, Banjan B, Albeshr MF, Mahboob S, Manzoor I, Das R. Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry. Life 2022;12:1300. [DOI: 10.3390/life12091300] [Reference Citation Analysis]
7 Le Corre P, Loas G. Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection. Front Pharmacol 2022;13:849095. [DOI: 10.3389/fphar.2022.849095] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mühle C, Kremer A, Vetter M, Schmid J, Achenbach S, Schumacher F, Lenz B, Cougoule C, Hoertel N, Carpinteiro A, Gulbins E, Kleuser B, Kornhuber J. COVID-19 and its clinical severity are associated with alterations of plasma sphingolipids and enzyme activities of sphingomyelinase and ceramidase.. [DOI: 10.1101/2022.01.19.22269391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]